Results
|
|
21.
|
|
|
|
22.
|
|
|
|
23.
|
|
|
|
24.
|
|
|
|
25.
|
|
|
|
26.
|
|
|
|
27.
|
|
|
|
28.
|
|
|
|
29.
|
|
|
|
30.
|
|
|
|
31.
|
|
|
|
32.
|
|
|
|
33.
|
|
|
|
34.
|
|
|
|
35.
|
|
|
|
36.
|
|
|
|
37.
|
The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers. [electronic resource] by
- Wang, Guo
- Lei, He-Ping
- Li, Zhi
- Tan, Zhi-Rong
- Guo, Dong
- Fan, Lan
- Chen, Yao
- Hu, Dong-Li
- Wang, Dan
- Zhou, Hong-Hao
Producer: 20090417
In:
European journal of clinical pharmacology vol. 65
Availability: No items available.
|
|
|
38.
|
|
|
|
39.
|
|
|
|
40.
|
The pregnane X receptor agonist St John's Wort has no effects on the pharmacokinetics and pharmacodynamics of repaglinide. [electronic resource] by
- Fan, Lan
- Zhou, Gan
- Guo, Dong
- Liu, Ya-Li
- Chen, Wang-Qing
- Liu, Zhao-Qian
- Tan, Zhi-Rong
- Sheng, Deng
- Zhou, Hong-Hao
- Zhang, Wei
Producer: 20111208
In:
Clinical pharmacokinetics vol. 50
Availability: No items available.
|